A detailed history of Linden Thomas Advisory Services, LLC transactions in Vericel Corp stock. As of the latest transaction made, Linden Thomas Advisory Services, LLC holds 42,981 shares of VCEL stock, worth $2.25 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
42,981
Previous 41,876 2.64%
Holding current value
$2.25 Million
Previous $2.18 Billion 9.48%
% of portfolio
0.3%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$41.71 - $52.9 $46,089 - $58,454
1,105 Added 2.64%
42,981 $1.97 Billion
Q1 2024

Apr 29, 2024

BUY
$32.52 - $52.33 $38,211 - $61,487
1,175 Added 2.89%
41,876 $2.18 Billion
Q4 2023

Feb 01, 2024

SELL
$30.85 - $37.09 $123 - $148
-4 Reduced 0.01%
40,701 $1.45 Billion
Q3 2023

Oct 20, 2023

BUY
$31.69 - $39.25 $3,676 - $4,553
116 Added 0.29%
40,705 $1.36 Billion
Q2 2023

Jul 27, 2023

BUY
$29.0 - $38.37 $1.18 Million - $1.56 Million
40,589 New
40,589 $1.52 Billion

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.47B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Linden Thomas Advisory Services, LLC Portfolio

Follow Linden Thomas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linden Thomas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Linden Thomas Advisory Services, LLC with notifications on news.